Skip to main content

Substitute Skin Grafts: Science to Business

Novitas, First Coast Service Options, and CGS Part B Medicare Administrative Contractors (MAC) finalized skin substitute policies: “greater than four applications of a skin substitute graft or CTP within the episode of skin replacement surgery (defined as 12 weeks from the first application of a skin substitute graft or CTP)” are “not medically reasonable and necessary.” Additionally, these policies list 58 products that meet the necessary FDA regulatory requirements for indications covered in the policy and 130 products that are considered non-covered. Join us to learn about these policy changes

Course Staff
Information Of Course
CME Online


Michael Warshaw, DPM Ulcer and Wound Debridement: CPT Codes and Medical Record Documentation

Allen Jacobs, DPM When is an Ulcer Not Just an Ulcer? Culture and Biopsy Considerations in Ulceration E/M

Michael Warshaw, DPM Review of ICD-10-CM Ulcer Coding

Allen Jacobs, DPM A Look at the New 2023 IWGDF Guidelines for Ulceration Management

Michael Warshaw, DPM CPT Codes for the Application of Skin Substitutes or CTPs

Allen Jacobs, DPM Evaluation and Management of Venous Ulceration

Michael Brody, DPM Wound Care and MIPS

Michael Warshaw, DPM Rule Changes Effective October 1. 2023

Allen Jacobs, DPM Medical-legal Considerations in Ulceration Management and Documentation

What Will You Learn?
  • Understand the appropriate indications for advanced wound care products
  • Understand appropriate billing for quality longitudinal care.
  • Understand the current guidelines for treatment of wounds.

Refund Policy

No refunds are available for online courses

Compliance Statement

The information contained in this presentation does not establish a standard of care, nor does it constitute legal advice.

The information is for general informational purposes only and is prepared from a perspective to aid in understanding the pathology.

In accordance with the Council on Podiatric Medical Education's Standards and Requirements for Approval of Providers of Continuing Education in Podiatric Medicine, any relevant financial relationships with commercial interests of faculty, planning committee, or any others who have influence over the content of this educational activity must be disclosed to program participants. There are no conflicts of interest to disclose for this program

Commercial Interest Statement

Commercial Interests: No commercial interest provided financial support for this continuing education activity.

Accreditation Statement

CME Online s approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. (CME Online has approved this activity for a maximum of 5.8 continuing education contact hours

Target Audience

Podiatrists, Podiatry Residents, Podiatry Students, and other medical professionals treating conditions

Financial Support

Commercial Interests: No commercial interest provided financial support for this continuing education activity.

Disclosure Declaration

Neither the speakers or planning committee have any disclosures to report


CME Online Inc